A Reflection On Care For Parkinson 's Disease

Neurology is one of the most unexplored fields in medicine; however, more recently there has been a spike in the amount of research being done in this specialty. This is because people are becoming more interested in neuroscience, including myself. I attended a pre-medical vocational high school, which exposed me to a greater amount of knowledge pertaining to the basics of anatomy and physiology, along with hands-on opportunities in a medical setting. It was here where I realized that I wanted to pursue a career in medicine; however, due to the fact medical field is very broad, I had no set specialty. This changed when I was exposed to the cruel manifestations of Parkinson’s Disease. During, sophomore year of high school, my grandfather passed away due to complications of Parkinson’s Disease. The way that a neurodegenerative disease was able to overtake a person in the manner that it did was shocking, and while it brought me great grief initially, it later intrigued me. I took up an interest in neuroscience and began to do my own research which culminated in various projects and applications throughout the remainder of my time in high school. These experiences have culminated in my decision to work toward a Cell Biology and

Parkinson 's disease is a progressive neurologic degenerative disease of the Central Nervous system. The brain produces Dopamine and Norepinephrine, which are chemicals needed for smooth muscle movement and coordination, heart rate, and blood pressure. Dopamine and Norepinephrine are released by basal ganglions that are produced in a bundle of nerve cells in the brainstem called substantia nigra. In Parkinson 's patients, the substantia nigra are destroyed and neither of the chemicals can be released into the body. (3) The decrease in Norepinephrine causes heart arrhythmia and low blood pressure, causing the person to get dizzy upon standing or tire easily. The lack of Dopamine, the smooth muscle movement and coordination controller is now gone, or significantly decreased, resulting in the first signs of Parkinson’s disease, pill-rolling, a one handed tremor and a decreased appetite. (2)

J.N., a 65-year-old Caucasian female with a history of anxiety and depression, presents for diagnostic testing at Saint Mary Medical Center in Hobart, Indiana to confirm or deny a diagnosis of Parkinson’s Disease, after presenting with recent onset of upper extremity tremor affecting both sides and facial masking. Patient history also includes bradykinesia, restlessness, fatigue, muscle weakness, and poor balance and coordination, all of which are common in a diagnosis of Parkinson’s Disease. J.N. was referred to the Neurology Department of Saint Mary Medical Center after a routine appointment with her Cardiologist, who noted the recent onset of additional signs and symptoms. J.N. is my mother and my inspiration for this assignment.

The World Health Organization projects that, by 2040, neurodegenerative diseases will become more common than cancer (Cashell, 2014). Parkinson’s Disease (PD) is widely listed as the second most common neurodegenerative disease (Wuong, 2012; Gillies et al., 2014; Cashell, 2014; Walker, Davidson, & Gray, 2012). This disease, usually characterized by a tremor, but featuring systemic effects, has been diagnosed in one to two percent of people over age 65 (Casey, 2013). Parkinson’s disease is incurable; the goal of the healthcare team is to help the patient to maintain function, independence and quality of life (Miertová et al., 2014; Magennis, Lynch, & Corry, 2014). In the discussion that follows, current understanding of the causes and treatment of PD will be summarized, along with examples of nursing interventions.

Many may not know Parkinson’s disease is the second most common neurodegenerative disorder in the world. This disease is most seen in the elderly starting at 62 years of age although, younger individuals can still have the disease it isn’t common. Parkinson’s make it difficult for its victims to carry out everyday activities that might have once been easy for them. As the disease progresses it makes it hard for the patient to do things like walk, stand, swallow and speak. A great deal of people don’t realize how helpful therapy can be when dealing with such disease!

When people hear the words Parkinson’s disease they think, “Isn’t that what Michael J. Fox has?” For those who are asking, “Who is Michael J. Fox?” He was the character Marty McFly in the “Back to the Future” movie and played on many TV shows. After being diagnosed with Parkinson’s disease, he set up an organization to research Parkinsonism. What the Michael J. Fox Foundation found was that 40 percent of the people living with Parkinson’s disease experience dystonia as an early symptom or a complication of treatment. This is the only blurb you see on the website about dystonia. In fact, it is so much like the other disorders out there that many people have never heard of it. The purpose of this paper is to inform

Parkinson’s disease, a type of dementia also known as idiopathic or primary parkinsonism, paralysis agitans, or hypokinetic rigid syndrome/HRS, is on the rise in the U.S. Each year there are over 60,000 new cases in the U.S. alone. With the average person diagnosed with Parkinson’s disease over the age of 65 and America’s rapidly growing elderly population, awareness and concern are becoming significant points of interest for many healthcare professionals.

Parkinson’s and Alzheimer’s disease are two degenerative brain diseases that differ in their symptoms, causes, treatment, physical and biological indicators. Per Hooley et al. (2017), Parkinson’ disease is thought to be caused by an extended reduction of dopamine, which the absence of constrains normal neural impulses in the brain. After some time, movements such as tremors, stammered speech, diminished or unintentional body movements are demonstrated. Those that suffer from Parkinson’s disease often have an incapability to swallow and muscle stiffness that affects muscles in their faces with mental deterioration occurring as the disease progresses. Parkinson’s disease can be traced to gender and genetics and most of those affected are men that have a family history of the disease (APA, 2013). Treatment for Parkinson’s disease encompasses dopamine precursors to increase the presence of dopamine.

Ramig and colleagues (2001) performed a study to examine the long-term effects of using Lee Silverman Voice Treatment (LSVT) to improve vocal function in individuals with Parkinson’s Disease (PD). Ramig and colleagues (2001) compared LSVT to received respiratory therapy (RET) to control for extraneous variables. Subjects were recruited from a variety of sources which helped to reduce recruitment bias (Ramig et al., 2001). Individuals with any laryngeal pathology unrelated to PD were excluded from the study (Ramig et al., 2001). All 33 subjects were stratified based on: age, time post-diagnosis, stage of disease, score on the unified Parkinson’s disease rating scale, and clinical ratings on speech and voice severity (Ramig et al., 2001). Subjects were then randomly divided into 2 groups and received either LSVT or RET provided in four one-hour weekly sessions for four weeks (Ramig et al., 2001).

Parkinson's disease is a progressive degenerative disorder of the central nervous system that affects the motor system. It is marked by tremor at rest, muscular rigidity, postural instability, and slow, imprecise movement. The most obvious symptoms are movement related, which include; shaking, rigidity, slowness of movement, difficult with walking, balance, and gait. Other motor symptoms include: posture disturbances, such as a decrease in arm swing, a forward flexed posture, and the use of small steps when walking. Speech and swallowing disturbances are also common motor problems that can appear as well to a patient with Parkinson's disease. Young adults rarely experience Parkinson's disease because it is more common to affect

Not only does Parkinson’s take away your ability to control your muscles, it also affects the control of your mind. These non-motor symptoms cause disabilities as well as lower the health-related quality of life for patients who are affected (Chaudhuri, 2011). Developing neuropsychiatric and other non-motor symptoms is not uncommon. Depression, anxiety, reduced cognitive function, insomnia, fatigue, and autonomic disturbances have been found in these patients (Poewe). Dementia is another major concern when dealing with Parkinson’s patients. The incidence of dementia occurring is close to eighty percent (Parkinson’s, 2010). Risk factors for the development of dementia include

Parkinson’s disease (PD) is the second most common neurodegenerative disorder in the world. Since an increasing number of people are reaching a high age, it is predicted that also the prevalence of Parkinson’s disease will be higher in the future. The symptoms of the disease are both motor symptoms like tremor and impairment of the gait, but along with that, psychological symptoms and memory loss are evident in many cases.

The question may arise, what exactly is Parkinson’s disease? Parkinson’s disease is a progressive degenerative neurological disorder, which means that it gets worse over time. PD is more common with increasing age affecting 1% of the population above 55, with 4-10% of cases having early onset before the age of 40 (XXXX). The average age of onset ranges between 58-62 years old and is more common in men than women. The disease itself is defined by the presence of lewy bodies in neurons and a loss of dopamine. Degenerative changes to the basal ganglia affect the nerve cells in the substantia niagra that produce dopamine. This results in a decrease in the production of dopamine that is getting to the brain. Dopamine is a neurotransmitter involved with regulating movement making early signs of PD primarily motor impairments and progression of this disease can range from

Parkinson’s Disease is a long-term progressive neurodegenerative disease consisting of motor system impairment, neuropsychiatric, and nonmotor features. The disease is characterized by the following key clinical features: bradykinesia, resting tremor, postural instability, and rigidity. These symptoms are due to the diminishing of dopamine in the nigrostriatal pathway and substantia nigra, which causes inhibition of the thalamus decreasing excitatory input to the motor cortex.1 Along with the key manifestations an individual with Parkinson’s Disease will experience problems associated with the disease or the antiparkinson medications. These co-occurring problems are hallucinations, dementia, daytime sleepiness, fatigue, depression, and pyschosis.2 Psychosis is a common problem in Parkinson’s Disease, and is characterized by paranoid delusions and hallucinations that are visual in nature.2 Risk factors for psychosis consists of advancing age, dementia, sleep disorders, and high doses of antiparkinson drugs.1

Parkinson disease (PD) is a progressive neurodegenerative disorder characterized mainly by physical and psychological disabilities. This disorder was named after James Parkinson, an English physician who first described it as shaking palsy in 1817 (Goetz, Factr, and Weiner, 2002). Jean- Martin Charcot, who was a French neurologist, then progressed and further refined the description of the disease and identified other clinical features of PD (Goetz, Factr, and Weiner, 2002). PD involves the loss of cells that produce the neurotransmitter dopamine in a part of the brain stem called the substansia nigra, which results in several signs and symptoms (Byrd, Marks, and Starr, 2000). It is manifested clinically by tremor,